T-cell masthead image

SGX203

Paper

Beclomethasone dipropionate for the treatment of mild-to-moderate crohn’s disease: An open-label, budesonide-controlled, randomized study

  • External Link
Tursi A, Giorgetti GM, Brandimarte G, et al. Beclomethasone dipropionate for the treatment of mild-to-moderate crohn’s disease: An open-label, budesonide-controlled, randomized study. Med Sci Monit. 2006; 12(6): PI29-32.
Paper

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

  • External Link
Filipovich AH, Weisdorf D, Pavletic S et al. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2005;11:945-955.
Paper

Long-Term Use of Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Graft-versus-Host Disease

  • External Link
Iyer RV, Hahn T, Roy HN et al. Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease. Biol Blood Marrow Transplant. 2005;11:587-592.
Paper

Optimised glucocorticoid therapy: the sharpening of an old spear

  • External Link
Buttgereit F, Burmester G-R, Lipworth BJ. Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet. 2005;365:801-803.
Paper

Beclomethasone versus placebo for chronic asthma

  • External Link
Adams NP, Bestall JB, Malouf R et al. Inhaled beclomethasone versus placebo for chronic asthma. Cochrane Review. In: The Cochrane Library. 2005;1. Chichester, UK: John Wiley & Sons, Ltd.
Paper

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

  • External Link
Fukuda T, Boeckh M, Carter RA et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood. 2003;102:827-833.
Paper

Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation

  • External Link
Hakki M, Riddell SR, Storek J et al. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood. 2003;102:3060-3067.
Paper

The quality of life in patients with Crohn’s disease

  • External Link
Cohen RD. 2002. The quality of life in patients with Crohn’s disease. Aliment Pharmacol Ther; 16: 1603–1609.
Paper

Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double‐blind placebo‐controlled study

  • External Link
Rizello F, Gionchetti P, D’Arienzo A et al. Oral beclomethasone dipropionate in the treatment of active ulcerative colitis: a double blind placebo controlled study. Aliment Pharmacol Ther. 2002;16:1109-1116.
Paper

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors

  • External Link
Marr KA, Carter RA, Boeckh M et al. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100:4358-4366.